MS — Morgan Stanley

Market sentiment is firmly positive after Q2 2026: equities trading revenue reportedly spiked 69% year over year, client assets reached $10 trillion, management raised the dividend 15%, and authorized a $20 billion buyback. Sell-side consensus is Buy (29 buy, 22 hold, 1 sell), with an average target near $239.50, and the stock has rallied about 45% over the trailing 12 months.

Revenue rose from $22.57B in Q3 2023 to $34.47B in Q2 2026, with YoY growth accelerating from roughly 10% in 2024 to about 22% in Q2 2026. Operating margin expanded from the mid-teens in 2024 to 21.5% in Q2 2026, and diluted EPS grew from $1.38 in Q3 2023 to $3.41 in Q2 2026. This is a genuine multi-quarter earnings inflection, not a one-quarter blip; the one distorting item is operating cash flow, which is often negative for broker-dealers due to balance-sheet/seasonality and should not be read as deteriorating profitability.

As of 2026-08-27, MS trades at 17.27x TTM earnings versus a 5-year average P/E of 15.26, and 2.68x sales versus a 5-year average of 2.28. Forward P/E is about 16.7x on next-FY EPS of $12.90. The 0.44 PEG ratio looks attractive only if you trust a high historical growth rate; next-FY EPS is essentially flat versus TTM, so relying on PEG is risky. This is a high-quality franchise, but the stock is rich versus its own history and not cheap on an absolute basis.

The market has already paid up for the strong earnings story: TTM EPS is $12.88 and next-FY consensus EPS is only $12.90, so the current price embeds little forward earnings growth. With a 17x multiple and estimates flat, further upside requires a beat-and-raise cycle in Q3/Q4 2026 or a re-rating on the wealth-management mix. If trading and investment-banking activity normalizes, the multiple has room to compress toward the 15x historical average.

As of 2026-08-27, RSI stood at 49.8, neutral, with price essentially flat to the 20-day and 50-day moving averages (-0.1% and -0.9%, respectively) and 13.4% above the 200-day. That suggests consolidation within an established uptrend after a strong rally, but not an overbought or oversold entry trigger. A cleaner entry might come on a pullback toward the 50-day or a breakout above the $232 area with volume.

• Equity-market levels and trading volumes drive MS's largest earnings swings in equities and investment banking.
• Interest-rate trajectory: cuts pressure net interest income but can boost capital-markets activity; uncertainty itself lifts trading volumes.
• Basel III endgame and other capital rules could constrain leverage and buyback intensity, though MS's 14.8% CET1 ratio offers a cushion.
• Wealth-management flows are tied to asset prices; higher equity markets feed fee revenues while a sharp drawdown would hit AUM-based fees.
• Ongoing AI and technology investment could widen margins but adds near-term cost pressure.

• Q3 2026 earnings, expected mid-October 2026, will test whether trading momentum and wealth net-new assets can continue.
• Upcoming investor conferences, including commentary from management at the Barclays Global Financial Services Conference.
• Execution of the $20 billion share-repurchase program and future dividend increases.
• M&A and equity issuance pipeline: continued recovery in deals would support investment-banking revenue.

• Market correction or volatility spike that hits trading, asset-gathering, and mark-to-market earnings; beta of 1.21 means amplified downside.
• Earnings normalization: with next-FY EPS roughly flat at $12.90, any pullback in equities trading from record levels could make the 17x multiple look stretched.
• Tighter-than-expected regulatory capital requirements could slow buybacks or constrain balance-sheet growth.
• Wealth-management fee compression, advisor attrition, or client outflows would undermine the stable-revenue thesis.

Morgan Stanley is a genuinely strong franchise with accelerating revenue, record operating margins, $10 trillion in client assets, and robust capital returns. But the stock is not inexpensive at roughly 17x earnings with flat forward estimates and rich versus its own historical valuation, so a new investor is paying a premium after a 45% run. The company is a high-quality compounder, but the risk/reward at $214.83 is more favorable after a pullback.

Theoretical fair value applies a 16.0x multiple to next-FY EPS of $12.896, a modest premium to MS's 5-year average P/E of 15.26 to reflect the stronger wealth and trading mix, but below the current 17.3x TTM multiple because forward estimates are flat and trading margins are near cyclical highs. This yields $206.34.